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The tripeptide A^^A^'-diacetyl-L-lysyl-D-alanyl-D-alanine (Ac2-LLys'-DAla^-DA]a^), which is the standard sub-
strate of the Zn""^G and serine R61 D-alanyl-D-alanine peptidases, and several LDD tripeptide analogues where
the size and/or the electrical charge of the side chains at position 1. 2 or 3 have been modified (alterations
affecting more than one position at the same time were not investigated) have been submitted to conformational
analyses based on both short-range and long-range interactions. Among the many backbone conformers of
minimal energy ofthe ^/t//, space that have been characterized, four types of conformers are the most probable
ones. Depending on the peptides, these conformers n:iay have varying relative probability P values so that the
leader conformer is not always the same, but, in all cases, the sum of their F values is 90% or more. With
the Gly', Gly^ or Gly^ analogues (which encompass a larger conformational space), the above IP values are
still as high as 35 — 50%. AU the above tripeptides bind to the serine D-alanyl-D-alanine peptidase and with the
exception of the Gly^ and Gly^ analogues, to the Zn^ "^  D-alanyl-D-alanine peptidase with virtually the same
efficacy, at least within a range of variation of the K^ values for the substrates or the Ki values for the inhibitors,
which is less than one order of magnitude. Sttaictural variations at position 1, 2 or 3 in the peptides that are
compatible with efficient binding are not necessarily compatible with substrate activity, thus converting the
modified peptides into competitive inhibitors. In particular, substrate activity requires a long side chain at
position 1 in the peptides. Conformational analyses of Ac2-LLys-DAla-DAia show that the main backbone has
a tendency to adopt a ring-like shape from which the LLys side chain protrudes as an extended structure. This latter
structure forms with the C-terminal D-alanyl-D-alanine an angle varying between 120" and 180" (depending on
the conformers) so that its N-terminal acetyl group is about 1 —1.5 nm apart from the scissile amide bond.
High turnover numbers (at enzyme saturation) also require a DAla at position 2 with both D-alanyl-D-alanine
peptidases and at position 3 in the case of the serine D-alanyl-D-alanine peptidase. Finally, all the conformers
of the LAla^ and LAla-^  analogues of Ac2-LLys-DAla-DAla fall outside the backbone conformational space that
comprises the ^.i//; angles exhibited by the four types of conformers of the LDD tripeptides. The LAla^ and
LAla^ tripeptide analogues do not bind to the serine D-alanyl-D-alanine peptidase (at least at a 10 mM con-
centration) but they behave as noncompetitive inhibitors ofthe Zn^^ D-alanyl-D-alanine peptidase.
The 18000-Mr G (from Streptomyces albus G [1]), the theoretical investigation which was undertaken to: (a) deter-
38000-A/TR61 (irom Streptomyces K6\ [2]) and the 53000-iV/r mine the most probable confomiation ofthe standard sub-
R39 (from Actinomadura R39 [3]) D-alanyl-D-alanine pepti- strate Ac2-LLys-DAla-DAla; (b) delineate how modifications
dases have been used as model enzymes to study the reactions at position 1, 2 or 3 affect this conformation; and (c) possibly
involved in the last step of bacterial wall peptidoglycan syn- relate the conformational changes thus induced, to the efFects
thesis and the mode of action of the ^-lactam antibiotics exerted on the kinetic parameters of the reactions. This study
[4,5]. The G enzyme is a metallo (Zn^^) peptidase [6,7]; it has been limited to the Zn"^ ^ G atid serine R61 enzymes
functions only as a hydrolase and is highly resistant to penicil- for which more complete data are available. Moreover, these
lin. The R61 and R39 enzymes are serine peptidases [8,9]; two enzymes have been crystallized [13,14] and their X-ray
they catalyse concomitant hydrolysis and transpeptidation structure analyses at 0.45-nm resolution have been or are
reactions and are moderately and extremely sensitive to close to being completed [7,15].
penicillin, respectively. In spite of these differences, an ex-
amination ofthe kinetic parameters ofthe reactions involving
a series of peptide analogues [standard reactions: Ac2-LLys'- MATERIALS AND METHODS
+ H.O ^  Ac^-LLys'-oAla^ + DAla^] has shown ^n-vmes and Peutides
[10-12] that whatever the enzyme, substrate activity requires ^ ^
the occurrence of a long side chain at position 1, strictly Fig.l is a schematic representation of the active centres
depends on a DAla at position 2 and accomodates, although ofthe Zn^ "^  and serine D-alanyl-D-alanine peptidases showitig
at the expense of the catalytic afficiency, Gly or a D-amino the interactions between the side chains at positions 1, 2 and 3
acid other than DAla at position 3. LAla at this C-terminal of Ac2-LLys-DAla-DAla and the corresponding pockets in





DAUuire2.5s ' and 55 s ', respectively. With the serine R61
on/yme, formation ofthe Michaelis complex (E + S ?=^E • S
with k-\lk\ = dissociation constant A") is thought to be a
rapid equilibrium process; moreover, experimental data in-
dicate that the rate of formation of the ester-linked aeyl-
en/ymc intermediate is probably smaller than the rate of
cn/ymc deacyiation (R. R. Yocum and J. L. Strominger, per-
sonal communication). Consequently, A'm is a valid measure
of A', the lower the A'm value the more effieient the initial
binding of the peptide to the enzyme. The exact mechanistic
properties of the Zn^'' G enzyme arc unkown and therefore
A'm = K (also used in the present work) must be regarded as
a first approximation.
Non-substrate peptide inhibitors (I) (catalytic efficieney
— 0) are peptides which inhibit the hydrolysis of the standard
substrate Ac2-LLys-DAIa-DAIa by the Zn "^" or serine D-alanyl-
D-alanine peptidase. Double-reciprocal plots of \jvv$\l
[Ac2-LLys-DAla-DAla] for various [I] values have been used
to establish whether the inhibition was eompetitive (C) or
non-cornpetitive (NC); for more details, see legend of Table 1.
The efficacy of the binding process (E + I^^^E " 0 has been
expressed as the K, term, the lower the K, value the more
efficient the binding.
t
Fig.l . Schematic representation of Aci-t.Lys-DAla-D.Ala bottttd to the
active centres of the Zn'* G and serine R6] D-alanyl-D-alanine peptidases.
In common with carboxypeplidase A and other enzymes acting on an-
ionic :iubslratcs. lho R61 enzyme possesses an active-site arginine residue
[16]. The dihedral angles (/»(, i//,, oji which govern the backbone con-
formation ofthe tnpoptide Ac^-LLys-DAIa-DAla (Ri = the A^''-acetylated
side chain of LLys) are shown m the lower part ofthe figure. The arrow
indicates the scissile bond
the carbonyi carbon of the sensitive amide bond of the
peptide in the vicinity ofthe Zn^^ ion in the G enzyme or the
correct serine residue in the R61 enzyme and result in the
establishment of the correct active-centre geometry. It has
been proposed [4] that initial binding of the peptide to the
enzymes mainly depends on the residues at positions 2 and 3
(the sequence oAla-DAla being favorable but not the only
efficient one) and that further processing of the Michaelis
complex mainly resuU,s from a specific interaction between the
side chain at position ] in the bound pcplidc and an activation
site of the enzyme cavity.
The peptides used are listed in Table 1. Some of them
are substrates and others are inhibitors. With peptide sub-
strates (S), the maximal velocity V of the reactions has been
expressed in turnover number (in s"') and substrate activity
has been expressed in terms of A'm and catalytic efficieney,
where catalytic efficieney = turnover number/A'm- The turn-




"^' is the sum of two terms
£-'"\ (1)
£•"" has been estimated using potential functions describing
forsional, van der Waals, electrostatic and hydrogen bond
energy. E^""^ (calculated using a grid of 20 ' for the ^, (/* angles
and 30 for the {y} angles) defines the conformation of an
/i-peptide (i.e. containing n residues) on the basis of only the
local interaetions which occur between the atoms surrounding
each residue (short-range interactions), thus ignoring the
interactions between the various residues:
_.
(2)
where {x\) stands for -/\, i]. l]^ • • • Ii^  turn. £'"' relates to
non-local, baekbone to backbone, side-chain to backbone
and side-chain to side-ehain intercations (long-range inter-
actions).
Short-Range Interactions
The probability PH^U^U (Xi)) that any residue / of an
/r-peptide assumes given 0., if/. and [x j^ angle values is
estimated according to a Boltzmann distribution
(3)
where R = gas constant and T= absolute temperature. Sum-
mation of the P^{4>i^^i,lxi\) values obtained for eaeh set
of xi angles gives the probability P*^ {(})., ip.) that residue i
assumes a given pair of (p.^if/i angles:
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Table I. Effteaey of hydrolysis of peptide substrates hy D-alanyl-D-alanyl peptida.ie
The release of the C-terminal residue was measured. Calalylic emciency = turnover number/A'^. NCI = noncompctitive inhibitor; Cl = com-
pelitive inhibilor. For coiidilion.s of synthesis and characterizaiion of Ihe peptides, sec [1 -3 ,10 -12] . Dala in the table are recaleulated from (1 - 3 .
10-12] exeept for the following. For the noneompetitive inhibitor peptides 2 and 3. the G enzyme (70 ng) and Ae2-LLys-DAla-i>Ala (at concen-
trations ranging over 0.37-1.5 mM) were incubated together (at 37'C and in n total volume of 45 |jl of 10 mM Tri,s/HCI buffer pll 7.8 containing
3mM MgClj) in the absence and in the presence of various coneentralions of either peptide 2 or peptide 3 (at eoncentrations ranging up to 0,9 mM).
The released D-alanine (in low amounts down to 1 nmol) was estimated aeeording to the method of Martin et al. [17] modified as follows. The
reaction mixtures were sueeessively heated at 100 "C for 1 min, cooled to 37 "C, supplemented with a solution (60|il) of D-amino acid oxidase (1 |ig)
and FAD (3 Mg) made in 100 niM Tris/HC! buffer pH 8.0. cooled to 18X, supplemented with a solution (20 i^l) of horse radish peroxidase
(0.65 i^g) and ABTS dye (35 |ig; from Boehringcr) made in water, and further ineubated at 18 C for 5 min. After addition of 250 )il water, the
absorbanee of the solutions was measured at 410 nm; 1 nmol of D-alanine produces an absorbanee of 0,10. The results were analysed using the
least-square program of Schilfetal. [18]. The values of the Fischer-Snedecor variables E were highly significant of a noneompetitive model
(/^ mcav > F^t). For Ki and K', values, see text. For peptide 4, assuming a competitive inhibition, the K, values were determined under !he following
eonditions of substrate and inhibitor concentrations: 0.8 mM Ae2-LLys-DAla-DAIa and 0 - 2 mM inhibitor in the ease of the G enzyme; 7 mM
Ac;-LLys-DAIa-DAla and 0 - 8 niM inhibitor in the ease ofthe R61 enzyme. For the competitive inhibitor peptide 5, the K, values were determined
under the following conditions of substrate and inhibitor eoncentrations: 0 .7 -3 mM Acj-LLys-DAla-DAIa and 0 - 1,5 mM inhibitor in the case
of the G enzyme; 1.5-7 mM Aei-LLys-DAla-DAIa and 0-8 .5 mM inhibitor in the case of the R6] enzyme, For peptide 14, the Ki values were
computed from [12] assuming a eompetitive inhibition. For peptide 15, the Ki values were computed from [12], The inhibition of the G enzyme
by Ac-DAla-DGIu was shown to be competitive [12]. That the inhibition of the R6] enzyme is also competitive is supported by the faet that












































































(no binding at 10 m,M)




























*' Substrate aetivity determined at 0.5 mM and expressed relatively lo that of Ae2-LLys-DAIa-DAla (I00°'o) tested under identieal conditions;
sec [10-12].
Plotting the PfC^,-, t/*;) values on a classical Ramachan-
dran's (f),ij/ map [21] permits visualization of regions R of
various probabilities. Fig. 2 shows the P" ((^,. t//,) map of an
LAla dipeptide unit; the regions of high probabihty are
designated by capita] letters A, B, C, D. E . . . and A*, B*,
C*, D*, E* . . . (for the two symmetrical regions in the ^. ij/
space, respectively). Region A corresponds to the well-known
right-handed a-helix; region B includes the 0,1// angles char-
acteristic of the ^-pleated slieets. In turn. Fig. 3 shows tlie
P° (</!»,(/') maps of an LAla unit in a C-terminal position.
Long-Range Interactions
When the £'" ' term of Eqn (1) is taken into account, the
probability P([4>p^i,{x\\]) that an n-peptide adopts a given




Ramachandran's maps like those shown in Fig.2 and 3
(see Materials and Methods; short-range interactions) can
be used to evaluate three types of probability P^. (a) Sutn-
mation of all the individual Pfiipi.tpi) values [Eqn (4)] which
are comprised in a given region R., gives the probability..P['(J?i),
according to which residue / occupies this particular region.
(b) On the basis of these individual PfiR-,) values, the prob-
ability P° (Ru Ri.-.Rn) that an w-peptide assumes a given
family Ri, R2 . • • R^ of backbone conformations is given by
(c) If the points within the various regions R are represented
by the corresponding small letters r, the probability P^\rij-2
. . . r„) which characterizes one conformer ri,rz . . . /„ of a
given family ^ 1 , R2 . • . Rn'is given by
P ' ^ i r u ' - i - . . / - n ) - P ^ ' i r O x P ^ i r . J x . . . x P " ( r , , ) .
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2 to 7 3 2
6 5 5p3 3
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Fig. 2, Prohiibility map P" Kp.ijjI of ihe Cx' — C ;^^  .sr^ment of a polypeptide chain wiih an I.Ala residue al position 2 (LAla dipeptide unit). Left:
probability map P'^  (< ,^)/') where capital, medium and small numbers give F° in "/o, °/oo and °/ooo- respeetively. The regions of high probability are
labelled vvith capital letters A, B, C, D, E and A*. B*, C*, D*, E* for (he symmetrical ones. Right: schematic probability map P° (tp.ip) of the
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Fig, 3, Probabiliiy map P'""
values between 180" and 0'
of an LAla unii at the C-ierniinal position. <pi values between 0 ' and —180' (not shown) are equivalent
The above approach has been applied to the standard
tripeptide Ac2-LLys-DAla-DAla and the peptide analogues
lifted in Table 1. The summation on the /_ angles [Eqn (4)]
has been restricted to those positions of the side chains for
which the corresponding local energy levels do not exceed
the optimal value by 21 kJ. The following observations have
been made, (a) The probability distributions P?((j)i,tj/i) (cal-
culated at 298 K) of the various residues which constitute the
peptides under consideration are shown in Fig. 4 (maps 1-15).
(b) The probabilities P?(/?i) according to which each resi-
due at position 1, 2 or 3 of the peptides, occupies the various
regions R of the Ramachandran's maps are given in Table 2.
They have been obtained by summing up the 25 individual
P'-((i>r'Pi) values of each ofthe regions A, B . . ., A*, B* . . .
of the maps of Fig.4. (c) The probability /*" (Ru ^2- ^i)
according to which any of the tripeptides assumes a giveti
family ^ i , 7?2. ^3 of backbone conformations can be calculated
from the data of Table 2. With Acz-LLys-oAIa-DAla, family
BB*B* has a P° (B, B*, B*) value of 0.70 x 0.61 x 0.79 = 34%
and is the most populated one. In turn, the families BE*B*,
EB*B*, EE*B*, etc. have P^ values of 8.3%, 5.3%, 1.3%, etc.
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Fig.4. Probability maps P" ((jy^ij/i for each residue at positions I (maps 1-5), 2 (maps 6- 10) and J (maps U -15} of the pep tide.s listed in Table 1.
Points of maximal probability in regions A, B, E, A*, B*, E*, are identified by small letters a, b. e, a*, b*, e*
226
Til Wo 2. Prohabititv Pi* ( R , ) ihat each re.miue at po.fitions I (residues 1-5), 2 (re.miues 6 - 10) and 3 (residues II - 15 > of the peptides listed in Table I





























































































































































































Table 3. <^.i/' angles at those points of ma.ximal P^ values of the
ami 3 /residues II —15 I of ihe peptides Us led in Table 1
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space of the maps of Fig, 4. each family Ru R2, R^ can be
characterized by its most probable conformer ri,r2,r3. With
Ac2-LLys-DAla-DAIa, the most probable conformers bb*b*,
be*b*, eb*b* and ee*b* of the corresponding families
BB*B*. BE*B*, EB*B* and EE*B*, have approximately the
same 0.072",, absolute P"" probability {i.e. 0.08x0.10x0.09
for conformer bb*b*). (e) The (j),ip angles of those points
ofthe ((^,,'/',) ^pace corresponding to maxima! P'^ values are
given in Table 3, Five points for the residues at positions 1
and 2, and two points for the residues at position 3 are taken
into consideration.
The following comments deserve attention, (a) Region B
for residues with the L configuration and region B* for
residues with the D configuration are the most probable ones,
(b) Substitution of one residue at position 1, 2 or 3 of the
tripeptide Ac2-LLys-DAla-DAla by another residue exhibiting
the same L or D configuration results in small shifts of prob-
ability, (e) Depending on the residues and their positions in
the peptides, the points of maximal probability do not occur
exactly at the same places, (d) There are several positions
of the LLys side chain which contribute to the probability
of the most probable conformers bb*b*, eb*b*, be*b* and
ee*b* of Ac2-LEys-DAla-DAla. The x angles which define
the most probable arrangement are x' = 60* for conformers
bb*b*andbe*b*,x^ = -60''forconformersee*b*andeb*b*.
and /^, /^, ;t* and X^ = 180' for the four conformers con-
sidered. In all cases, the LLys side chain is an extended
structure protruding from the peptide backbone. As shown
in Fig. 5, the side chain of eonformer bb*b* and that part
of the peptide backbone where the carbonyl carbon which
undergoes nucleophilic attack is located, form between them
an angle of about 120''. Moreover, the carbonyl carbon of
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Ihe sensitive amide bond imd the A^'-acetylaled end of ihc
side chain are separuted from each other by a spanning
distance of about 1.3 nm.
When the long-range interactions arc included, the prob-
ability distribution P is calculated from Eqn (5) (see Materials
and Methods). Computation of the denominator of this
equation would have required an exceedingly long time.
Consequently, the investigations were limited to the com-
putation ofthe numerator for well-selected conformers, thus
permitting calculation ofa relatively probability distribution
sensi t fve bond
1 nm
P. The selected eonformers, eaeh of them representing a given
family, were those corresponding to the points ofthe (fl)i.t}/i)
space of maximal P" values (for the (()JI/ angles, see 7'able 3).
The results are given in Table 4. Note that when £'"' is taken
into account, the most probable conformers ee*b*, bb*b*,
be*b* and eb*b* of Aci-LLys-DAla-oAla have relative P
values of 36.3",., 3I,7'Y,, n . 2 % and 7.3%, respectively (while
they were equiprobable al the P^ level; see above). The rela-
tive P values of the dipeptides Ac-DAla-oAla and Ac-DAIa-
DGIU were similarly estimated; conformers b*b* and e*b*
are largely predominant (Table 4). The whole conformational
spaee of Ac-DAIa-DAla was scanned and the denominator
of Eqn (5) computed. The results were that families B*B* and
E*B* also largely predominate (34,2% and 16.2%, respec-
tively).
As a result of the above studies, several backbone con-
formations have been characterized for each of the peptides
listed in Table 1. For each peptide, that conformer which
characterizes itself by the highest P value is referred to as the
leader conformer. The leader conformer and the other most
probable conformers which have been used to define the
conformational characteristics of a given peptide represent
at least 90% of all the conformers taken into account
aiive values > 90%; see Table 4).
Fig.5. Side chain to backbone arrangement found in conformer bb*b* of
Ac2-LLys-DAla-DAla
RELATIONSHIPS BETWEEN CONFORMATION
AND SUBSTRATE OR INHIBITOR ACTIVITY
Ac2-LLys-DAla-DAla is the peptide whieh exhibits the
highest substrate activity with the G and R61 D-alanyl-
D-alanine peptidases (Table 1). Fig. 6a —d are stereoscopic
views ofthe leader conformer ee*b* and the three other most
probable conformers bb*b*. be*b* and eb*b* (i^ /^ reiauvs
values — 93%). The N" and TV'-acetyl groups are situated at
the right and left sides, respectively, of the lower part of the
Table 4. Relative probability distribution of eonformers at the P level
The predominaung or leader conformeTs are printed in bold-face type. Note that when Gly occurs at position 1, 2 or 3 (peptides 13, 8 and 9),
the corresponding points b or b* are equivalent (see maps 5, 9 and 14 in Fig, 4), Also that when LAla occurs at position 2 or 3 (peptides 2 and 3), the
points b
Peptide
















































































































































" beb* = 40.2; bbb* = 25.2; eeb* = 16.6; ebb* - 9.6; eab* = 2.6; bed = 1.5; ea*b* = 1.4. S = 97.1
'' bb*b - 32.1; ee*b = 24,1; ea*b - 15.2; be*b = 15,1; eb*b - 7.2; bab = 1.8; ba*b = 1.1, I = 96.6.
= beb* = 34.5; eeb* = 11,2. Z = 87.
*• ee*d = 31; bb*d* = 6.3; bb*d = 5.1; be*d = 4.9; ea*e* = 3.3; bad = 1.9, Z = 92.2.
' ee*d = 3.5, r = 9 1 , 2
Fig, 6. Stereoscopic diagrams of the four most probable conformers of
Ac.-LLys-D.-ilci-D.-tla: ee*b* (Fig.al. bb'b* (Fig.b/. be*b* (Fig.c) and
eb*b* (Fig.Jl. The leader conformer is ee*b*
ShorU'itittg the Neutral Side Chain at the l.-Centre ^ ^
of Ac2-t.Lys-nAla-t>Ala
These alterations (peptides 1 and 10-15 in Tables I and 4)
give rise only to minor modifications of the equilibrium
distribution. The LPr,v,u., (bb*b*, eb*b*, be*b*, ee*b*)
values ofthe Ac2-LA2bu', Ae-LHse' and Ac-LAla' analogues
remain higher than 90%,. As expected, the Ac-Gly' analogue
encompasses a larger proportion of the conformational space;
however, conformer ee*b* remains the leader, the Z/'^ iaDve
(bb*b*, eb*b*, be*b*, ee*b*) is still 50% and the e*b*-b*b*
probability of the C-terminal dipeptide remains close to 90 %.
When compared to Ac2-LLys-DAla-DAla, the modified
peptides bind somewhat less effectively to the G enzyme, the
A'm value being increased at the most by a faetor of 3 to 10.
The main efTect, however, is on the V value which is deereased
by a faetor of 100 — 200 for the Gly' and LAla' analogues.
At the limit, the dipeptide Ae-DAla-DAla (b*b* = 6L8%;
e*b* = 34.1%) is a nonsubstrate competitive inhibitor.
The data obtained with the R61 enzyme are limited. As
observed with the G enzyme, however, substrate aetivity
requires a long side chain at the L-centre of the tripeptide
and enzyme activity is inhibited by Ac-DAla-DAla.
Two other observations deserve attention. With both G
and R61 enzymes, the A^  value of Ae-DAia-DAla is much
higher than the Am values of Ac-Gly-DAla-DAla or Ae2-LLys-
DAla-DAla, showing that the tripeptide backbone is of im-
portance in the binding ofthe peptide to the Zn^ "^  and serine
enzymes. It should also be noted that Ac-DAla-DGIu (b*b*
=^ 41.6"^; e*b* = 55%) has a much lower A'i value than
Ac-DAla-DAla showing that the sequence DAla-DGlu permits
a more efficient binding.
figures (the same general orientation is used in Fig.5). The
following observations can be made, (a) Irrespective of the
conformer considered, the ;V'-acetyiated side chain of the
LLys residue (R\) is an extended structure whieh protrudes




(b) The A/*-acetylated side chain and the C-terminal DAla-
DAla portion of the peptide backbone form at the L-centre
of the peptide. an angle of 120 in conformers bb*b* and
be*b*. and 180 in conformers ee*b* and eb*b*. (e) The
C-terminal DAla somewhat folds back towards the TV"-
acetylated terminal group in conformers eb*b*, be*b* and
ee*b*. the strongest curvature of the loop being observed
in conformer ee*b*. Ring-like structures have also been
proposed for the peptide units of the bacterial wall peptido-
glycan by Barnickel et al. [22].
In order to determine the relation.ships which must exist
between conformation and substrate activity, four types of
structural alterations of Ac2-KLys-DAla-DAla have been in-
vestigated and the conformational changes thus induced
(Table 4) have been related to the effects exerted on the
kinetic parameters of the reactions (Table 1). Note that all
the peptides of Table I and the corresponding ones of Table 4
are identical except peptide II (UDP-MurNAc-GIy-DGlu-
[LHse-DAia-DAIa] cf. Ac-LHse-DAla-DAla).
Replacing oAla hy Other D~Atnino Aeids at Position 2 or 3
of Ae2'LLyS'DAla-DAla
Replacing DAla at position 2 by DLeu or DGIU (peptides 4
and 5 in Tables 1 and 4) considerably enhanees the probability
of conformers bb*b* and be*b*, respeetively, the stabilization
effeet resulting from the establishment of elose contacts be-
tween the DLeu or the DGIU side chain and the LLys side
chain (Fig. 7a, b). Replaeing DAla at position 3 by DLeu or
DLys (peptides 6 and 7 in Tables 1 and 4) considerably
enhances the probability of conformers ee*b* and be*b*,
respectively, the observed conformational shifts resulting
from the establishment of good contacts between the DLeu or
DLys side chain and the peptide backbone (Fig. 7c, d). All
these alterations modify the probability patterns of the four
most probable eonformers ee*b*, bb*b*, be*b* and eb*b*,
but the Z/'reiative (ee*b*, bb*b*, be*b*, eb*b*) values always
remain higher than 90%.
The modified peptides bind to the R61 enzyme with the
same effieaey as Ae2-LLys-DAla-DAla but modifieations at
position 3 (peptides 6 and 7) decrease the V value by a factor
of 10 and modifications at position 2 (peptides 4 and 5)
abolish substrate activity so that the peptides are converted
into nonsubstrate inhibitors. The AT^  of Ac2-LLys-DAla-DAla
and the A; of the competitive inhibitor Ac2-LLys-DG]u-DAla
are virtually identical.
As observed with the R61 enzyme, binding ofthe modified
peptides to the G enzyme is not or is very little affected and
modification at position 2 (peptides 4 and 5) abolish catalysis,
converting the peptides into nonsubstrate competitive in-
hibitors. When compared with Ac2-LLys-DAla-DAla (Km
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Fig. 7. Stereoscopic diagrams of the leader eonformers of Aci-LLys-oLeu-
DAla (bb*h*: Fig.a): Ac2-LLys-DGlu-DAla (be*b*: Fig.b); Acj-LLys-
oAla-oLeu (ee*b*: Fig.c): Aci-LLys-oAla-oLys (be*b*: Fig.d)
= 0.33 mM). the DLeu"' or DLys^  analogues have Km values,
and the DLeu^ or DGIU'^ analogues have Ki values, that are
either unchanged or at the most increased by a factor of 2.5
(in fact such variations are at the limit of the experimental
errors). However, contrary to that which is observed with
the R61 enzyme, modifications at position 3 (peptides 6 and 7)
have little effect on the V of the reactions catalysed by the G
enzyme. With peptide 6, the K value is deereased at the most
by a factor of 3. With peptide 7. the estimated 2.4-fold in-
creased Km value well explains the 2.8-fold decreased catalytic
efficiency so that the K value is probably unaltered. Similarly,
the Ac2-LLys-DA]a-DGlu (not shown in Table 1) has a Am
value of 0.7 mM and a catalytic efficieney of 3000 M"^ s " \
also suggesting that the V value is identieal to that of Ae^-
LLys-DAIa-DAla.
Replaeing DAla hy Gly at Position 2 or 3
of Ae2-LLys-DAla-DAla
The Gly^ and Gly^ analogues (peptides 8 and 9 in
Tables 1 and 4) encompass a larger conformational space.
With the Gly^ analogue, conformers bb*b* and eb*b* dis-
appear and are replaced by conformers eeb* and beb* while
conformer beb* becomes leader (Fig. 8a). With the Gly"'
analogue, conformer eb*b* disappears and is replaced by
conformer e*b*b* while conformer ee*d becomes leader
(Fig. 8b). In all cases, however, the lP,,uu^^ (bb*b*, eb*b*,
be*b* and ee*b*) values are still about 35-40%.
Fig, 8, Stereoscopic diagrams of the leader conformers of Aci-iLys-Gly-
DAta (beb*: Fig. a) and Acz-t^Lys-DAla-Gly (ee*d: Fig.bJ
Fig. 9. Slereoscopie diagrams of the leader eonformers of Acz-i-Lys-LAla-
DAIQ (beb* : Fig. a) and Aci-Ltys-DAla-LAla (bb*b: Fig. b)
With the R6I enzyme and when eompared to Ac2-LLys-
DAIa-DAla, the A'm value of the Gly^ analogue is unaltered
and that of the Gly^ ^ analogue is increased by a factor of 3,
It thus follows that the 660-fold and 13-fold decreased
catalytic efficiencies that are observed with the Gly' and Gly^
analogues, respeetively, are mainly, if not entirely, due to
deereased K values.
With the G enzyme and in marked contrast to that whieh
is observed with the R61 enzyme, the A',,, values for the Gly-*
analogue and, to a much greater extent, the Gly- analogue
are considerably increased (when compared to Ac2-LLys-
DAla-DAIa) so that the observed decreased catalytic efficien-
cies are due mainly, if not entirely, to a loss of binding
efficieney.
Replacing DAla hy LAla at Position 2 or 3
of Ac 2-LLys-D Ala-DAla
These alterations (peptides 2 and 3 in Tables 1 and 4)
result in probability patterns where eonfovmers ee*b*, bb*b*,
be*b* and eb*b* are no longer present. With the LAla-
analogue, the EP,,^,,,,, (eeb*, bbb*, beb*, ebb*) is 91.6%
and the leader conformer is beb* (Fig. 9a); with the LAla-'
analogue, the IP.da.ive (ee*b, bb*b, be*b, eb*b) is 78^-, and
the leader eonformer is bb*b (Fig. 9b). Note that when LAla
occurs instead of nAla al posilii>n 2 or 3 (,sei- iiKip.s it and 10
«uul II .ind 15 in liii, 4), the points b and h* diller from
each olhcr onh b> f 40 or 40 for holh <!> ami i// angles;
lun\\•^L• .^ ihe niclliy! groups arc di.sphtced from one side lo
!ho oihor side of Ihe pl;tne (compare Fig. 9b and 6b).
I lie I Akr itnd i Al;r^  analogues are not substrates of any
ol the on-'ymcs under consideration. Al a 10 mM concen-
tration, they are noi (vcognized by the R6I on/yme and do
not bind to it. Both o( them, however, inhibit the hydro-
lysis of Ae:-LLys-DAIa-DAta by the G cn/yme but the inhibi-
lion IS clearly non-eompetiiive, indicating that the ternary
complex l-S! can be formed. Binding of the l Ala" and LAla'
analogues to the Ci cn/ymc has little inlUicnce on the A'm
value of Ac:-i Lys-t)Ala-DAla, suggesting that these peptide
inhibitors do not occupy the main substrate binding site (i.e.
the en/yme pockets where the C-terminal DAla-DAla sequence
undergoes binding; see Fig, 1). The values of A'i (dissociation
constant of E - l - l ^ F l ) and A; (dissociation constant of
ES-1- l ^ E S I ) are 0.34 mM and 1.06 mM, respeetively, for
Ac:-LLys-LAla-DAla and 0.6 mM and 0.7 mM, respectively,
for Aci-LLys-DAla-LAla. Since A,;, ~ A,,, • A',7A'i, it follows
that An, ^ A'm with both inhibitors,
DISCUSSION
The serine R61 and Zn^ "^  G D-alanyl-D-alanine peptidases
act on anionic peptides in whieh they hydrolyse the amide
bond extending between two D-alanine residues in an a posi-
tion to a freecarboxyl group. Study ofthe effects of alterations
of the side chains at position 1, 2 or 3 of the standard sub-
strate Ac2-LLys^-DAla--DAla^ has led to the following ob-
servations. Alterations affecting more than one position at
the same time were not investigated,
a) The size and/or the electrical charges of the side chain
at position 1, 2 or 3 of LDD tripeptides have relatively little
influence on the backbone conformation of the tripeptides.
Indeed, among the many conformers of minimal energy of
the (piipi space that characterize Ac2-LLys-DAla-DAIa and
the LDD tripeptide analogues that have been studied, con-
formers ee*b*, bb*b*. be*b* and eb*b* are the most probable
ones. Although depending on the peptides, these conformers
may have varying relative probability P values (so that the
leader conformer is not always the same), the sum of the P
values is always 90*'(, or more. When compared to the LDD
tripeptides, the Gly', Gly"^  or Gly"* analogues encompass a
larger eonformational space but the above EP values are
still as high as 35-50%.
b) All the above peptides exeept the Gly- and Gly^ ana-
logues in the case of theZn"^ enzyme, bind with mueh the same
efficacy to the active centres of either the Zn^ "*^  or the serine
enzyme (at least within a range of variation of the Am or Ai
values less than one order of magnitude). Henee, side chains
of varying structures and/or electrical charges at position 1,
2 or 3 that have little influence on the relative probability
distribution of conformers, have also no or little influence
on the binding of the peptides to the enzymes. In other
studies. Virudachalam and Rao [23] have suggested that
D-alanyl-D-alanine peptidase activity (and therefore binding
ofthe substrate to the enzyme) depends on specific (})il/ angle
values of the fourth and fifth residues of the pentapeptide
units of the peplidoglycan; these values fal! in the allowed
regions as defined by the data of Tables 3 and 4. Other con-
clusions brought about by the present studies are that (a) as
the high A'i values of Ac-DAIa-oAla indicate, the entire length
of Ihe Iripeplide backbone (and noi only its C-terminal di-
peplidc) is involved in the binding process; and (b) side
cluiiirs having in least ihe size of that of i>Ala at position 3
i\{K\, more imporlant, at position 2 are required for effieient
binding of the Iripeptide to the Zn^^G enzyme (but not to
the serine R6! enzyme). A final observation also deserves
attention which is that somehow, the dipeptide Ac-oAla-DGIu
binds to the Zn^^ and serino enzymes more effectively than
Ihe dipeptide Ac-DAIa-uAla, but with the same efficacy as
that of Ac2-LLys-t>Ala-DAIa.
e) Binding of a peptide to the enzymes is not always
followed by catalysis. Structural features at position 1, 2 or 3
in the peptides that are compatible with efficient binding may
result in low turnover numbers and, at the limit, may com-
pletely prevent catalysis, thus conferring on the modified
peptides the property to behave as competitive inhibitors.
With the serine enzyme, replacing DAla at position 2 (i.e.
that residue whose earbonyl earbon is transferred to H2O)
by other D-amino acids or glycine and shortening the side
chain at position 1 have such effects, Replacing DAla at posi-
tion 3 (i.e. theleavinggroupof the reaetion) by other D-amino
acids or Gly markedly decrease the velocity of the reactions
catalysed. The same observations apply to the Zn^^ enzyme
exeept that (a) replaeing DAla at position 2 by Gly has its
main adverse effeet on the binding proeess (see above); and
(b) replaeing DAla at position 3 by other D-amino acids or
Gly is compatible with high turnover numbers.
d) The main baekbone of Ac^-LLys-DAla-DAla has a
tendency to adopt a ring-like shape from which the LLys side
chain protrudes as an extended structure forming with the
C-terminal DAla-DAla, an angle varying between 120' and
180 (depending on the conformers). One may hypothesize
that such a disposition is important in that it probably confers
on the COOH terminal group, the scissile amide bond, and
the three side chains at positions 1, 2 and 3, respectively, the
capacity of interacting regiospecifically and stereospecifically
with the different binding and catalytic sites of the active
centres of the enzymes. Binding of a peptide to the enzyme
occurs in the absence of any side chain at position 1 but sub-
strate activity does require a long side chain at this position.
By interacting with the relevant pocket of the enzyme cavity
(Fig.l), the LLys side chain of Aci-LLys-DAla-DAla, whose
A"-acetyl group is located about 1 — 1.5 nm from the scissile
amide bond, is thought to induce conformational ehanges in
the protein that result in the establishment of a catalytically
active serine residue [4,24], As the kinetic data show, the
interaction of the LLys side chain with the corresponding
enzyme pocket does not significantly increase the efficacy of
the binding step. It may be tbat the decrease of free energy
caused by this interaction is utilized to distort the enzyme-
substrate system (the enzyme, the substrate, or both) and to
bring it closer to the transition state. When compared to a
peptide that does not possess a long side chain at position 1,
Ae2-LLys-DAla-DAla would interaet with the enzyme with the
same binding constant but the resulting eomplex would be
considerably different (distorted versus non-distorted).
e) In the benzylpenicillin and cepbaloglycine molecules
(Fig. 10), \p2 and ^3 are fixed to the indicated values (Table 5)
by the lactam and the thiazolidine (dihydrothiazine) rings,
while (l>2 and \}/3 determine the orientation of the amino-acyl
substituent and that ofthe C-terminal grouping, respeetively.
The dihedral angles 4>3 in cephaloglycine and (j)2 in both
benzylpenicillin and cephaloglycine widely differ from h
and ipi in the peptides (Table 5). In addition, (O2 is 136" in
benzylpenicillin, 154' in cephaloglycine and 180' in the
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Table 5, Dihedral angles ofthe nAla-pAla portion of Acj-t-Lys-DAla-oAla and of the fused ring systems of benzylpenicillin and eephaloglyeine
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Fig. to. Dihedral angles around the ^-laciam endocyelic amide bond in
the penicillins (a) and A^-cephalosporins (b)
peptides. Yet, the penicillins and ^^-cephalosporins bind to
the Zn^ "*" G and serine R61 enzymes and moreover, with this
latter enzyme,, part of the steps involved in normal catalysis
occur so that the serine residue of the enzyme centre effec-
tively attacks the carbonyl carbon of the ^-lactam amide
bond to give rise to a penicilloyl-enzyme or cephalosporoyl-
enzyme intermediate [4]. With the Zn^^ enzyme, however,
binding of penicillin or z)^-cephalosporin is essentially rever-
sible. The enzyme cavity of the Zn^^G and serine R61
D-alanyl-D-alanine peptidases thus appears to be able to bind
LDD peptides and j5-lactam antibiotics in spite of the fact
that only a small portion of their eonformationa! spaces
coincide, suggesting different modes of binding for these two
types of compounds- To some extent, this situation is rem-
iniscent of that of carboxypeptidase B. In addition to its
affinity toward substrates with terminal basic amino acids,
ear boxy peptidase B also possesses intrinsic activity against
substrates with non-basic hydrophobic amino acids and the
modes of binding of these two types of substrate are not the
same [27].
0 Neither Ac2-LLys-LAla-DAla nor Ac2-LLys-DAIa-LAla
binds to the serine enzyme (at least at a 10 mM concentra-
tion). With the Zn^ •*" enzyme, these two analogues behave as
noneompetitive inhibitors. The ternary eomplex ESI formed
between enzyme, substrate and inhibitor is non-productive.
Moreover, the inhibitors exert no or little influence on the
A'm value of Ae2-LLys-DAla-DAla, indicating that they do not
oecupy the site where binding of the substrate occurs. Note
that peptides that are neither carbonyl donors nor amino
acceptors are also known to be involved in some allosteric
action on the R39 serine D-alanyl-D-alanine peptidase [281.
The most probable conformers of both LAIa^ and LAla^
analogues differ from those of the LDD peptides. However,
the 02,t/'2 spaees defined by conformers bbb* and ebb* of
the LAla^ analogues and by conformers bb*b* and eb*b* of
Ac2-LLys-DAIa-DAla are only distant from each other by
-|'4O' or -40' ' . Similarly, the (1)3.^1^3 point of conformers
ee*b, bb*b, be*b and eb*b of the LAla^ analogue is only
distant from the (^ 3, t//3 point of Ac2-LLys-DAla-DAIa by +40"
or —40: Henee, the inability ofthe LAla^ and LAla^ ana-
logues to bind to the active eentres of the Zn^ "^  and serine
enzymes might be due to a disallowed orientation of the
corresponding methyl groups (which when compared with
Ac2-LLys-DAIa-DAla are displaced from one side to the other
side of the plane) as well as to a perturbed backbone con-
formation.
g) The conformational studies described in this paper
should be useful in exploring the architecture and functioning
of the aetive eentres of the D-alanyl-D-alanine peptidases.
Their full significance, however, must await completion of
other studies now in progress which deal with the design of
other types of enzyme inhibitors and the X-ray analysis at
0.17 nm and amino acid sequencing ofthe Zn "^^  G and serine
R61 enzymes.
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